Artigo Revisado por pares

Clinical predictive factors of unresponsiveness to omalizumab in patients with chronic spontaneous urticaria

2020; Oxford University Press; Volume: 183; Issue: 6 Linguagem: Inglês

10.1111/bjd.19312

ISSN

1365-2133

Autores

J. Castagna, Lorraine Bernard, F. Hacard, F. Delcroix, A.‐S. Darrigade, Jean‐François Nicolas, Évelyne Decullier, Audrey Nosbaum, F. Bérard,

Tópico(s)

Coagulation, Bradykinin, Polyphosphates, and Angioedema

Resumo

British Journal of DermatologyVolume 183, Issue 6 p. 1124-1126 Research Letter Clinical predictive factors of unresponsiveness to omalizumab in patients with chronic spontaneous urticaria J. Castagna, Corresponding Author castagnajulie@gmail.com orcid.org/0000-0002-9983-9521 Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Contribution: Conceptualization (lead), Data curation (lead), Methodology (lead), Resources (equal), Writing - original draft (lead), Writing - review & editing (lead)Search for more papers by this authorL. Bernard, Hospices Civils de Lyon, Public Health Department, Lyon, France Claude Bernard University Lyon I, Lyon, France Contribution: Formal analysis (lead)Search for more papers by this authorF. Hacard, Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Claude Bernard University Lyon I, Lyon, France Contribution: Resources (equal), Validation (equal), Visualization (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorF. Delcroix, Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Claude Bernard University Lyon I, Lyon, France Contribution: Resources (equal), Validation (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorA.-S. Darrigade, Department of Dermatology, Bordeaux University Hospitals, Bordeaux, France Contribution: Resources (equal), Validation (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorJ.-F. Nicolas, Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Claude Bernard University Lyon I, Lyon, France Contribution: Conceptualization (equal), Methodology (equal), Project administration (equal), Resources (equal), Supervision (equal), Validation (equal), Visualization (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorE. Decullier, Hospices Civils de Lyon, Public Health Department, Lyon, France Claude Bernard University Lyon I, Lyon, France Contribution: Formal analysis (lead)Search for more papers by this authorA. Nosbaum, Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Claude Bernard University Lyon I, Lyon, France Contribution: Conceptualization (equal), Methodology (equal), Project administration (equal), Resources (equal), Supervision (equal), Validation (equal), Visualization (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorF. Bérard, Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Claude Bernard University Lyon I, Lyon, France Contribution: Conceptualization (equal), ​Investigation (equal), Methodology (equal), Project administration (lead), Resources (equal), Supervision (lead), Validation (equal), Visualization (equal), Writing - original draft (lead), Writing - review & editing (lead)Search for more papers by this author J. Castagna, Corresponding Author castagnajulie@gmail.com orcid.org/0000-0002-9983-9521 Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Contribution: Conceptualization (lead), Data curation (lead), Methodology (lead), Resources (equal), Writing - original draft (lead), Writing - review & editing (lead)Search for more papers by this authorL. Bernard, Hospices Civils de Lyon, Public Health Department, Lyon, France Claude Bernard University Lyon I, Lyon, France Contribution: Formal analysis (lead)Search for more papers by this authorF. Hacard, Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Claude Bernard University Lyon I, Lyon, France Contribution: Resources (equal), Validation (equal), Visualization (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorF. Delcroix, Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Claude Bernard University Lyon I, Lyon, France Contribution: Resources (equal), Validation (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorA.-S. Darrigade, Department of Dermatology, Bordeaux University Hospitals, Bordeaux, France Contribution: Resources (equal), Validation (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorJ.-F. Nicolas, Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Claude Bernard University Lyon I, Lyon, France Contribution: Conceptualization (equal), Methodology (equal), Project administration (equal), Resources (equal), Supervision (equal), Validation (equal), Visualization (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorE. Decullier, Hospices Civils de Lyon, Public Health Department, Lyon, France Claude Bernard University Lyon I, Lyon, France Contribution: Formal analysis (lead)Search for more papers by this authorA. Nosbaum, Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Claude Bernard University Lyon I, Lyon, France Contribution: Conceptualization (equal), Methodology (equal), Project administration (equal), Resources (equal), Supervision (equal), Validation (equal), Visualization (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorF. Bérard, Hospices Civils de Lyon, Clinical Immunology and Allergology, Pierre-Bénite, France Claude Bernard University Lyon I, Lyon, France Contribution: Conceptualization (equal), ​Investigation (equal), Methodology (equal), Project administration (lead), Resources (equal), Supervision (lead), Validation (equal), Visualization (equal), Writing - original draft (lead), Writing - review & editing (lead)Search for more papers by this author First published: 12 June 2020 https://doi.org/10.1111/bjd.19312Citations: 3 Funding sources: none. Conflicts of interest: A.N. has received investigator grants, lecturer honoraria or consulting payments from Sanofi-Regeneron, Pierre Fabre, Janssen-Cilag, Celgene, Lilly, LEO Pharma, Galderma, AbbVie, Medac and Pfizer. F.B. received investigator grants, lecturer honoraria or consulting payments from Novartis. J.-F.N. received honoraria from Novartis. A.N. and F.B. contributed equally. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume183, Issue6December 2020Pages 1124-1126 RelatedInformation

Referência(s)
Altmetric
PlumX